LLY
1,020.07
-1.55%↓
JNJ
244.95
+0.71%↑
ABBV
228.53
-1.79%↓
NVS
165.17
-0.6%↓
MRK
121.6
+0.04%↑
LLY
1,020.07
-1.55%↓
JNJ
244.95
+0.71%↑
ABBV
228.53
-1.79%↓
NVS
165.17
-0.6%↓
MRK
121.6
+0.04%↑
LLY
1,020.07
-1.55%↓
JNJ
244.95
+0.71%↑
ABBV
228.53
-1.79%↓
NVS
165.17
-0.6%↓
MRK
121.6
+0.04%↑
LLY
1,020.07
-1.55%↓
JNJ
244.95
+0.71%↑
ABBV
228.53
-1.79%↓
NVS
165.17
-0.6%↓
MRK
121.6
+0.04%↑
LLY
1,020.07
-1.55%↓
JNJ
244.95
+0.71%↑
ABBV
228.53
-1.79%↓
NVS
165.17
-0.6%↓
MRK
121.6
+0.04%↑
24h
Praegune
Min
3.39
Max
3.5300000000000002
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +197.78% upside |
Järgmine tulemuste avaldamine | 27. märts 2026 |
|---|
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
15. dets 2025, 16:30 UTC
Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment
DJ
Loe
1. okt 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Loe
10. märts 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Loe
10. märts 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
10. märts 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 10.75 USD 197.78%
Kõrge 17 USD
Madal 4.5 USD
Põhineb 2 Wall Streeti analüütiku instrumendi Fortress Biotech Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
2 ratings
2
Osta
0
Hoia
0
Müü
Põhineb 2 analüütiku instrumendi Fortress Biotech Inc aktsia reitingul - viimase 3 kuu andmed.
$